| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |